[1]Cui Y, Xin H, Tao Y, et al. Arenaria kansuensis attenuates pulmonary fibrosis in mice via the activation of Nrf2 pathway and the inhibition of NF-kB/TGF-beta1/Smad2/3 pathway[J]. Phytother Res, 2021, 35: 974-986. [2]Tang H, Gao L, Mao J, et al. Salidroside protects against bleomycin-induced pulmonary fibrosis: activation of Nrf2-antioxidant signaling, and inhibition of NF-κB and TGF-β1/Smad-2/-3 pathways[J]. Cell Stress Chaperones, 2016, 21: 239-249. [3]Zaafan MA, Haridy AR, Abdelhamid AM. Amitriptyline attenuates bleomycin-induced pulmonary fibrosis: modulation of the expression of NF-κβ, iNOS, and Nrf2[J]. Naunyn Schmiedebergs Arch Pharmacol, 2019, 392: 279-286. [4]Tai W, Deng S, Wu W, et al. Rapamycin attenuates the paraquat-induced pulmonary fibrosis through activating Nrf2 pathway[J]. J Cell Physiol, 2020, 235: 1759-1768. [5]Jin H. Imrecoxib inhibits paraquat-induced pulmonary fibrosis through the NF-κB/Snail signaling pathway[J]. Comput Math Methods Med, 2020, 2020: 6374014. doi: 10.1155/2020/6374014. [6]李美崎, 邓俊, 王宋平. 苦参碱减轻百草枯诱导的模型小鼠肺纤维化[J]. 基础医学与临床, 2022, 9: 1385-1390. [7]Yang H, Hua C, Yang X, et al. Pterostilbene prevents LPS-induced early pulmonary fibrosis by suppressing oxidative stress, inflammation and apoptosis in vivo[J]. Food Funct, 2020, 11: 4471-4484. [8]Xue H, Li M. Protective effect of pterostilbene on sepsis-induced acute lung injury in a rat model via the JAK2/STAT3 pathway[J]. Ann Transl Med, 2020, 8: 1452. doi: 10.21037/atm-20-5814. [9]Ashcroft T, Simpson JM, Timbrell V. Simple method of estimating severity of pulmonary fibrosis on a numerical scale[J]. J Clin Pathol, 1988, 41: 467-470. [10]Kim KK, Kugler MC, Wolters PJ, et al. Alveolar epithelial cell mesenchymal transition develops in vivo during pulmonary fibrosis and is regulated by the extracellular matrix[J]. Proc Natl Acad Sci U S A, 2006, 103: 13180-13185. [11]Kikuchi N, Ishii Y, Morishima Y, et al. Nrf2 protects against pulmonary fibrosis by regulating the lung oxidant level and Th1/Th2 balance[J]. Respir Res, 2010, 11: 31. doi: 10.1186/1465-9921-11-31. [12]Schnaper HW, Jandeska S, Runyan CE, et al. TGF-beta signal transduction in chronic kidney disease[J]. Front Biosci (Landmark Ed), 2009, 14: 2448-2465. [13]Lovisa S, LeBleu VS, Tampe B, et al. Epithelial-to-mesenchymal transition induces cell cycle arrest and parenchymal damage in renal fibrosis[J]. Nat Med, 2015, 21: 998-1009. [14]Song L, Chen TY, Zhao XJ, et al. Pterostilbene prevents hepatocyte epithelial-mesenchymal transition in fructose-induced liver fibrosis through suppressing miR-34a/Sirt1/p53 and TGF-β1/Smads signalling[J]. Br J Pharmacol, 2019, 176: 1619-1634. |